FORM Holdings Corp. (XSPA)
(Delayed Data from NSDQ)
$2.49 USD
+0.09 (3.75%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.42 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.49 USD
+0.09 (3.75%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.42 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
XpresSpa Group, Inc. (XSPA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 20% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Armata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of 0% and 98.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Bright Health Group (BHG) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Bright Health (BHG) delivered earnings and revenue surprises of -18.42% and 14.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of -5% and 4.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing AMN Healthcare Services (AMN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
XpresSpa Group, Inc. (XSPA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 33.33% and 23.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics, Inc. (CODX) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 44.44% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 37.50% and 4.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sotera Health Company (SHC) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Sotera Health Company (SHC) delivered earnings and revenue surprises of 15.79% and 2.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Down 38.6% in 4 Weeks, Here's Why XpresSpa Group, Inc. (XSPA) Looks Ripe for a Turnaround
by Zacks Equity Research
XpresSpa Group, Inc. (XSPA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Implied Volatility Surging for XpresSpa (XSPA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to XpresSpa (XSPA) stock based on the movements in the options market lately.
Implied Volatility Surging for XpresSpa (XSPA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to XpresSpa (XSPA) stock based on the movements in the options market lately.